eToro - Investment and Trading Platform Home Page
SearchSearch
Languages
Language
LoginSign up
Login
Stocks-TERN-Terns Pharmaceuticals Inc

Terns Pharmaceuticals Inc TERN

‎$‎8.15-0.35(-4.12%)(1D)
• Delayed prices by Nasdaq • in USD
Invest in Terns Pharmaceuticals Inc
Today
Create an eToro account to buy TERN stock on a secure, user-friendly, multi-asset trading platform.
Buy Terns Pharmaceuticals Inc
Buy Terns Pharmaceuticals Inc
Terns Pharmaceuticals Inc TERN
Buy TERN
Analyst Forecast
i
This 12-month forecast is based on a composite of analyst projections. Based on analysts with a rating of 4+ stars. This is not a prediction made by eToro nor is it investment advice.
Consensus
Strong Buy
Price Target
15.29
Based on analysts who covered TERN

Trending stocks

See stocks with the biggest daily volume spikes vs. their 3-month average.

Terns Pharmaceuticals Inc News

More about Terns Pharmaceuticals Inc
Terns Pharmaceuticals Inc is an innovative biotech firm dedicated to pioneering and marketing therapeutic solutions on an international scale. Its work is primarily focused on the fields of liver disease and cancer.

Operating in the biotechnology industry, Terns Pharmaceuticals Inc aims to mitigate the pathophysiological impacts of liver diseases like Non-alcoholic Steatohepatitis (NASH) and cancer. Although it operates independently, TERN boasts strategic partnerships with renowned pharmaceutical organisations. Its services encompass all stages of drug development, from discovery to clinical development, to bring novel, life-changing drugs to market.

Monitor TERN's share price by adding it to your eToro watchlist.
VIEW MORE   

TERN Stock Price Chart

‎8.81‎
Past Month
1D
1W
1M
6M
1Y
3Y
MAX
Sign up for full charts powered byTradingView logo
*Past performance is not an indication of future results
Asset negative trend

The Terns Pharmaceuticals Inc share price is on the decline this week.

i
A ‘rising’ price indicates that the weekly price has increased by more than 0.5%.
A price ‘on the decline’ indicates that the weekly price has decreased by more than 0.5%.
A ‘stable’ price indicates that the change in weekly price is between -0.5% and 0.5%.
The Terns Pharmaceuticals Inc share price today is ‎$‎8.15, reflecting a ‎-4.12‎% change over the last 24 hours and ‎-0.97‎% over the past week. The current market capitalization of TERN is ‎$‎713.22M with an average volume in the last three months of 1.13M. The stock has a P/E ratio of -7.8 and a dividend yield of 0%. With the stock’s beta sitting at 0.97
Market Cap
i
Total value of all asset shares, calculated by multiplying the price by the total number of outstanding shares.
‎$‎713.22M
Day’s Range
i
Shows the high and low prices of the day.
‎$‎8.04 - ‎$‎8.51
52W Range
i
Shows the high and low prices of the last year.
‎$‎1.84 - ‎$‎11.35
Average Volume (3M)
i
The average number of shares traded per day over the last three months.
1.13M
Price-Earnings Ratio
i
The result of this asset’s share price divided by its earnings per share.
-7.8
Revenue
i
The total income generated by this company’s goods and services last year.
‎$‎0
Dividend (Yield)
i
How much a company pays out in dividends each year relative to its stock price.
‎$‎0 (0%)
Prev Close
i
The final price of this asset at the end of the last trading day.
‎$‎8.15
EPS
i
A company’s total earnings divided by the number of shares it has issued.
‎$‎-1.05
Beta
i
A measure of whether any asset does, or doesn’t, experience price moves in line with the broader market.
0.97
What Is Terns Pharmaceuticals Inc?
Terns Pharmaceuticals Inc is an innovative biotech firm dedicated to pioneering and marketing therapeutic solutions on an international scale. Its work is primarily focused on the fields of liver disease and cancer.

Operating in the biotechnology industry, Terns Pharmaceuticals Inc aims to mitigate the pathophysiological impacts of liver diseases like Non-alcoholic Steatohepatitis (NASH) and cancer. Although it operates independently, TERN boasts strategic partnerships with renowned pharmaceutical organisations. Its services encompass all stages of drug development, from discovery to clinical development, to bring novel, life-changing drugs to market.

Monitor TERN's share price by adding it to your eToro watchlist.
Get Started

How can I buy Terns Pharmaceuticals Inc stocks?

To purchase Terns Pharmaceuticals Inc:
01

Create an eToro account:

Sign up for an eToro account and verify your identity.
02

Deposit funds:

Deposit funds into your eToro account using your preferred payment method.
03

Search and purchase:

Search the Terns Pharmaceuticals Inc (TERN) page and place an order to buy Terns Pharmaceuticals Inc.
Buy TERN
Looking for more information? Check out our guide on Academy.
Top Guides
Our top picks for the most relevant guides from the eToro Academy
Top Dividend Stocks for 2025
Top Dividend Stocks for 2025
Gear up for 2025 with these top dividend stocks. Dive into the potential of Verizon, Exxon Mobil, NextEra, Coca Cola, Unicredit through eToro’s expert analysis.
Read More
Stock Trading And Investing For Beginners
Stock Trading And Investing For Beginners
New to online trading? Learn the basics with eToro. What are stocks? trading vs. investing, what are the risks, and how to open a trade, step by step.
Read More
AI Stocks Poised for Growth in 2025
AI Stocks Poised for Growth in 2025
Gear up for 2025 with AI stocks. Dive into the potential of Nvidia, Broadcom, CrowdStrike, Arista Networks, and Amphenol, through eToro’s expert analysis.
Read More
Go to the Academy >
Graph
Buy Terns Pharmaceuticals Inc
Invest in Terns Pharmaceuticals Inc
Today
Create an eToro account to buy TERN stock on a secure, user-friendly, multi-asset trading platform.
Get Started

FAQ

The current price of TERN is ‎$‎8.15.
The average price target for Terns Pharmaceuticals Inc is ‎$‎15.29. Sign up to eToro for detailed analyst forecasts and price targets.
Analysts offer forecasts for Terns Pharmaceuticals Inc based on market trends, financial reports and projected growth. Check the latest forecast for future price movements.
The market capitalisation of Terns Pharmaceuticals Inc is ‎$‎713.22M
Based on 6 analysts offering recommendations for TERN in the last 3 months, the overall consensus is Strong Buy.
Daily Movers
Explore the biggest stocks movers on the market.
English (UK)Check icon
Deutsch
Français
Polski
Português
Dansk
Suomi
Español
Русский
العربية
Nederlands
Svenska
Română
Italiano
中文
繁體中文
Norsk
Čeština
Tiếng Việt
Scroll to top